Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid Leukemia
Status:
Active, not recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
This phase II trial studies how well vosaroxin and cytarabine work in treating patients with
untreated acute myeloid leukemia. Drugs used in chemotherapy, such as vosaroxin and
cytarabine, work in different ways to stop the growth of cancer cells, either by killing the
cells, by stopping them from dividing, or by stopping them from spreading.